BIODELIVERY SCIENCES INTL IN's ticker is BDSI and the CUSIP is 09060J106. A total of 159 filers reported holding BIODELIVERY SCIENCES INTL IN in Q2 2020. The put-call ratio across all filers is 1.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $8,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q4 2020 | $8,000 | -20.0% | 2,000 | -23.7% | 0.00% | – |
| Q3 2020 | $10,000 | -9.1% | 2,620 | 0.0% | 0.00% | – |
| Q2 2020 | $11,000 | +10.0% | 2,620 | 0.0% | 0.00% | – |
| Q1 2020 | $10,000 | -41.2% | 2,620 | 0.0% | 0.00% | – |
| Q4 2019 | $17,000 | +112.5% | 2,620 | +31.0% | 0.00% | – |
| Q3 2019 | $8,000 | -11.1% | 2,000 | 0.0% | 0.00% | – |
| Q2 2019 | $9,000 | -18.2% | 2,000 | 0.0% | 0.00% | – |
| Q1 2019 | $11,000 | +57.1% | 2,000 | 0.0% | 0.00% | – |
| Q4 2018 | $7,000 | -96.4% | 2,000 | -87.5% | 0.00% | -100.0% |
| Q4 2014 | $192,000 | -29.7% | 16,000 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $273,000 | +41.5% | 16,000 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $193,000 | +116.9% | 16,000 | +52.4% | 0.00% | +100.0% |
| Q1 2014 | $89,000 | +43.5% | 10,500 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $62,000 | – | 10,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 1,575,000 | $6,615,000 | 4.38% |
| 1492 Capital Management LLC | 790,863 | $3,322,000 | 1.91% |
| Rubric Capital Management LP | 3,516,124 | $14,768,000 | 1.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 9,530,000 | $40,026,000 | 0.79% |
| Zebra Capital Management LLC | 144,241 | $606,000 | 0.77% |
| KNOTT DAVID M | 370,230 | $1,555,000 | 0.70% |
| Nantahala Capital Management | 5,123,671 | $21,519,000 | 0.67% |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 3,593,893 | $15,094,000 | 0.66% |
| EMC Capital Management | 98,933 | $416,000 | 0.32% |
| ALGERT GLOBAL LLC | 175,170 | $736,000 | 0.21% |